Agitation Associated With Alzheimer’s Disease: Current Best Practices and Planning for the Future

Get guidance from experts on managing patients with AAD, including best practices for using currently available pharmacologic options, insights on how emerging pharmacologic agents might affect future clinical practice, and patient factors to consider when choosing a therapeutic agent.

Share

Program Content

Activities

AAD
Agitation Associated With Alzheimer’s Disease: Current Best Practices and Planning for the Future
Video
Congratulations: You achieved a completion on 04/09/2022

Released: June 15, 2023

Expires: June 14, 2024

Activities

Managing AAD
Optimal Assessment and Management of Agitation in Alzheimer’s Disease
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 05, 2023

Activities

AAD
Agitation Associated With Alzheimer’s Disease: Current Best Practices and Planning for the Future
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 26, 2023

Faculty

cover img faculity

George T. Grossberg, MD

Henry & Amelia Nasrallah Professor
Director, Geriatric Psychiatry
Department of Psychiatry & Behavioral Neuroscience
St Louis University School of Medicine
St Louis, Missouri

cover img faculity

Susan Scanland, MSN, CRNP, GNP-BC, CDP

National Dementia Expert
CEO and Founder, Dementia Connections LLC
Clarks Summit, Pennsylvania 

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from Otsuka America Pharmaceutical, Inc. and Lundbeck.

Otsuka America Pharmaceutical, Inc. and Lundbeck